FundedIQ
Biotechnology

Atelerix Life Sciences: Funding, Investors & Team (Sep 2026)

atelerixlifesciences.com LinkedIn Charlottesville, United States 1-10 employees
Biotechnology Health Care Life Science Therapeutics
Total raised
$650k
Rounds
1
Latest
Seed
Oct 2022

Atelerix Life Sciences has raised $650k across 1 funding round on record, the most recent a Seed of $650k announced in Oct 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Atelerix Life Sciences Company Profile and Key Stats

Total funding raised
$650k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$650k in Oct 2022
Employees
1-10
reported band
Headquarters
Charlottesville, United States

Latest funding round on record: Oct 2022.

Atelerix Life Sciences Funding Rounds

Date
Round
Amount
Seed
$650k

Atelerix Life Sciences Founders and Leadership Team

Name
Role
Contact
David G Kalergis
CEO

No contact details are on record for this team yet.

Atelerix Life Sciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
16,575
$3.1M

Atelerix Life Sciences' latest round of $650k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Atelerix Life Sciences in Biotechnology and Charlottesville

Companies Similar to Atelerix Life Sciences

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Atelerix Life Sciences Funding FAQs

How much funding has Atelerix Life Sciences raised?

Atelerix Life Sciences has raised $650k across 1 round on record. The most recent is a Seed of $650k announced in Oct 2022.

When did Atelerix Life Sciences last raise funding?

Atelerix Life Sciences' most recent funding round on record is a Seed of $650k, announced in Oct 2022.

Who is the CEO of Atelerix Life Sciences?

David G Kalergis is listed as CEO at Atelerix Life Sciences.

Where is Atelerix Life Sciences headquartered?

Atelerix Life Sciences is based in Charlottesville, Virginia, United States.

How many employees does Atelerix Life Sciences have?

Atelerix Life Sciences is in the 1-10 employee band.

How does Atelerix Life Sciences' funding compare to other Biotechnology startups?

Atelerix Life Sciences' latest round of $650k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Atelerix Life Sciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Atelerix Life Sciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.